Table 2.
Univariate and multivariate analysis of overall survival in patients with prostate cancer (n = 60).
| Variable for overall survival | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
| Age(years) | 0.897 | |||||
| ≤60 vs. >60 | 1.043 | 0.547-1.989 | ||||
| Lymph node metastasis | 0.071 | |||||
| Negative vs. positive | 1.819 | 0.950-3.485 | ||||
| Distant metastasis | 0.218 | |||||
| M0 vs. M1 | 1.501 | 0.786-2.863 | ||||
| Tumor stage | 0.011 | 0.105 | ||||
| ≤T2 vs. >T2 | 2.364 | 1.220-4.580 | 0.565 | 0.283-1.128 | ||
| PSA at initial diagnosis (ng/mL) | 0.008 | 0.294 | ||||
| ≤20 vs. >20 | 2.45 | 1.263-4.754 | 0.671 | 0.318-1.414 | ||
| miR-205 expression | P < 0.001 | 0.021 | ||||
| Low vs. high | 3.251 | 1.675-6.313 | 0.417 | 0.198-0.878 | ||